Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
NEW CATEGORY
Under this new category (i) Reactive Attachment Disorder,(ii)
Disinhibited Social Engagement Disorder, (iii)PTSD, (iv) Acute
Stress Disorder, (V)Adjustment Disorders
3. Adjustment Disorders
Characterized by an emotional response to a stressful event such
as financial issues, medical illness, or relationship problem
4
ETIOLOGY
A. NEUROBIOLOGICAL PERSPECTIVE
l. Neuroimaging Technique
II. Neurotransmitters
1.Cortisol
• PTSD patients have increased cortisol levels in the brain that is
implicated in hippocampus that results to impaired memory
Stressful/ life-threatening event > amygdala> cortisol is released
through the activation of the Hypothalamus Pituitary Adrenal Axis >
Hypothalamus secretes cortisol-releasing factor/ hormone (CRF/H)
which triggers pituitary gland to release Adreno Corticotropic
hormone (ACTH). In turn ACTH signals adrenal gland to release 30
other hormones cortisol, epinephrine (adrenaline), or
norepinephrine (noradrenaline), necessary for the fight-flight-or-
freeze mechanism (i.e increased blood flow to the muscles, blood
pressure)
Normally, once cortisol reaches the hypothalamus (i.e. when the
stressor is gone). it terminates the production of cortisol (negative
feedback). However, in PTSD, there is less sensitivity to negative
feedback.
One theory is, people with PTSD have lower levels of cortisol prior to
trauma than people who do not have PTSD (not used to stress). Thus,
there is lesser sensitivity to the negative feedback > continuous
production of cortisol > shrinking of hippocampus > memory is
impaired
B. PSYCHOLOGICAL PERSPECTIVE
i. Psychodynamic perspective
1.This perspective hypothesizes that the trauma has reactivated a
previously inactive, yet unresolved psychological conflict.
People already experiencing increased symptoms of anxiety or
depression before a trauma occurs are more likely to develop PTSD
following the trauma
6
C. SOCIO-CULTURAL PERSPECTIVE
ii. Resilience
1.When faced with a traumatic event, some people seem to rise to the
challenge and show resilience
TREATMENT
A. Pharmacological
a. Selective Serotonin Reuptake Inhibitors (SSR1s)
i. Antidepressants (Sertraline, Fluoxetine)
ii. Antianxiety drugs (Lorazepam)
B. Psychotherapy
a. Psychodynamic therapy
b. Cognitive-behavioral therapy
i. Imaginal exposure through virtual reality (VR) technology
ii. Systematic desensitization
8